高级检索
当前位置: 首页 > 详情页

PROGRESSION OF MYOPIC MACULOPATHY IN CHINESE CHILDREN WITH HIGH MYOPIA A Long-Term Follow-Up Study

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, China. [2]Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin Eye Hospital, Tianjin, China. [3]Tongren Eye Care Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China. [4]Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China. [5]Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls -University Heidelberg, Mannheim, Germany.
出处:
ISSN:

关键词: myopic maculopathy high myopia peripapillary diffuse choroidal atrophy parapapillary gamma zone children

摘要:
To investigate the progression of myopic maculopathy (MM) and associated factors in highly myopic Chinese children.In this retrospective observational case series, biometric fundus features were morphometrically measured on photographs. Myopic maculopathy was defined as recommended by the Meta-analysis of Pathologic Myopia Study Group.The study included 274 children (mean age:11.7±2.5 years; mean refractive error:-7.66±1.87 diopters) with a mean follow-up of 4.9±1.2 years. MM progression was detected in 52 eyes (18.9%; 95% confidence interval [CI]:14.3%,23.7%). In multivariable analysis, MM progression was associated with a decrease in refractive error (odds ratio [OR]:0.72;95%CI:0.56,0.92;P<0.001) (i.e. higher myopization) and enlargement of parapapillary gamma zone (OR:7.68;95%CI:1.63,36.2;P=0.002). Incident peripapillary diffuse choroidal atrophy noted in 47 of 236 eyes (20.0%; 95%CI, 14.8%-25.2%), was correlated with a decrease in refractive error (OR:0.70;95%CI:0.54,0.92;P=0.009) (i.e., higher myopization) and greater gamma zone enlargement (OR:8.28;95%CI:1.33,51.7;P=0.02).Myopia in schoolchildren may have a considerable risk of progressing to MM. Enlargement of parapapillary gamma zone was a main independent risk factor.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 2 区 医学
小类 | 2 区 眼科学
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 眼科学
JCR分区:
出版当年[2019]版:
Q1 OPHTHALMOLOGY
最新[2023]版:
Q2 OPHTHALMOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, China. [2]Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin Eye Hospital, Tianjin, China. [3]Tongren Eye Care Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
通讯作者:
通讯机构: [1]Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, China. [2]Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin Eye Hospital, Tianjin, China. [*1]Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin Eye Hospital, Tianjin Medical University, Nankai University, No. 4. Gansu Road, He-ping District, Tianjin 300020, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)